When FZD7 is inhibited by an antibody coated nanoshell in breast cancer cells, the EMT phenotype is reduced, identifying FZD7 as targetable in cancer cells and offering a potential delivery approach for FZD7 chemoprevention [120]. Here, FZD7 is linked to breast cancer.